Add to ORKGthe role of the TREM2 p.R47H variant as a risk factor for Alzheimer’s disease and frontotemporal dementi
BACKGROUND Sequence variants, including the epsilon 4 allele of apolipoprotein E, have been associat...
Rare variation in TREM2 has been associated with greater risk for Alzheimer's disease (AD). TREM2 en...
Homozygous mutations in TREM2 have been recently identified by exome sequencing in families presenti...
Background: A rare variant in the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) gene has ...
A rare variant in TREM2 (p.R47H, rs75932628) was recently reported to increase the risk of Alzheimer...
A rare variant in TREM2 (p.R47H, rs75932628) was recently reported to increase the risk of Alzheimer...
Abstract Background A rare variant in the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) g...
Rare coding variants in TREM2 and their association with the susceptibility towards Alzheimer’s dise...
The triggering receptor expressed on myeloid 2 (TREM2) is an immune phagocytic receptor expressed on...
Frontotemporal dementia (FTD) is a clinically and genetically heterogeneous disorder. Rare TREM2 var...
Homozygous mutations in exon 2 of TREM2, a gene involved in Nasu-Hakola disease, can cause frontotem...
Abstract Background The R47H variant of Triggering Receptor Expressed on Myeloid cells 2 (TREM2) con...
Background: Triggering receptor expressed on myeloid cells 2 (TREM2) is an important modulator of in...
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Late-onset AD (LOAD), is the mo...
Recent evidence suggests that rare genetic variants within the TREM2 gene are associated with increa...
BACKGROUND Sequence variants, including the epsilon 4 allele of apolipoprotein E, have been associat...
Rare variation in TREM2 has been associated with greater risk for Alzheimer's disease (AD). TREM2 en...
Homozygous mutations in TREM2 have been recently identified by exome sequencing in families presenti...
Background: A rare variant in the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) gene has ...
A rare variant in TREM2 (p.R47H, rs75932628) was recently reported to increase the risk of Alzheimer...
A rare variant in TREM2 (p.R47H, rs75932628) was recently reported to increase the risk of Alzheimer...
Abstract Background A rare variant in the Triggering Receptor Expressed on Myeloid cells 2 (TREM2) g...
Rare coding variants in TREM2 and their association with the susceptibility towards Alzheimer’s dise...
The triggering receptor expressed on myeloid 2 (TREM2) is an immune phagocytic receptor expressed on...
Frontotemporal dementia (FTD) is a clinically and genetically heterogeneous disorder. Rare TREM2 var...
Homozygous mutations in exon 2 of TREM2, a gene involved in Nasu-Hakola disease, can cause frontotem...
Abstract Background The R47H variant of Triggering Receptor Expressed on Myeloid cells 2 (TREM2) con...
Background: Triggering receptor expressed on myeloid cells 2 (TREM2) is an important modulator of in...
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Late-onset AD (LOAD), is the mo...
Recent evidence suggests that rare genetic variants within the TREM2 gene are associated with increa...
BACKGROUND Sequence variants, including the epsilon 4 allele of apolipoprotein E, have been associat...
Rare variation in TREM2 has been associated with greater risk for Alzheimer's disease (AD). TREM2 en...
Homozygous mutations in TREM2 have been recently identified by exome sequencing in families presenti...